Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Notes Payables: 2014

  • Abeona Therapeutics' Notes Payables was N/A to $400,000 in Q4 2014 from the same period last year, while for Dec 2014 it was $400,000, marking a year-over-year change of. This contributed to the annual value of $400,000 for FY2014, which is N/A change from last year.
  • According to the latest figures from Q4 2014, Abeona Therapeutics' Notes Payables is $400,000, which was up 60.00% from $250,000 recorded in Q3 2014.
  • Abeona Therapeutics' 5-year Notes Payables high stood at $400,000 for Q4 2014, and its period low was $250,000 during Q3 2014.
  • In the last 1 years, Abeona Therapeutics' Notes Payables had a median value of $325,000 in 2014 and averaged $325,000.